Familial thoracic aortic aneurysm and aortic dissection
|
0.500 |
Biomarker
|
disease |
CLINGEN |
Loss of fibulin-4 disrupts collagen synthesis and maturation: implications for pathology resulting from EFEMP2 mutations.
|
26220971 |
2015 |
Familial thoracic aortic aneurysm and aortic dissection
|
0.500 |
Biomarker
|
disease |
CLINGEN |
Fibulin-4 E57K Knock-in Mice Recapitulate Cutaneous, Vascular and Skeletal Defects of Recessive Cutis Laxa 1B with both Elastic Fiber and Collagen Fibril Abnormalities.
|
26178373 |
2015 |
Familial thoracic aortic aneurysm and aortic dissection
|
0.500 |
Biomarker
|
disease |
CLINGEN |
Decreased expression of fibulin-4 in aortic wall of aortic dissection.
|
23518852 |
2014 |
Familial thoracic aortic aneurysm and aortic dissection
|
0.500 |
Biomarker
|
disease |
CLINGEN |
Recessively inherited severe aortic aneurysm caused by mutated EFEMP2.
|
22440127 |
2012 |
Familial thoracic aortic aneurysm and aortic dissection
|
0.500 |
Biomarker
|
disease |
CLINGEN |
Fibulin-4 deficiency results in ascending aortic aneurysms: a potential link between abnormal smooth muscle cell phenotype and aneurysm progression.
|
20019329 |
2010 |
Familial thoracic aortic aneurysm and aortic dissection
|
0.500 |
Biomarker
|
disease |
CLINGEN |
Fibulin-4 conducts proper elastogenesis via interaction with cross-linking enzyme lysyl oxidase.
|
19855011 |
2009 |
Familial thoracic aortic aneurysm and aortic dissection
|
0.500 |
Biomarker
|
disease |
CLINGEN |
Perturbations of vascular homeostasis and aortic valve abnormalities in fibulin-4 deficient mice.
|
17293478 |
2007 |
Familial thoracic aortic aneurysm and aortic dissection
|
0.500 |
Biomarker
|
disease |
CLINGEN |
Targeted disruption of fibulin-4 abolishes elastogenesis and causes perinatal lethality in mice.
|
16478991 |
2006 |
Familial thoracic aortic aneurysm and aortic dissection
|
0.500 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
|
|
|
Prostatic Neoplasms
|
0.310 |
Biomarker
|
group |
CTD_human |
Downregulation of several fibulin genes in prostate cancer.
|
17929269 |
2007 |
Malignant neoplasm of prostate
|
0.310 |
Biomarker
|
disease |
CTD_human |
Our recent microarray analysis suggested downregulation of three fibulins, FBLN1, FBLN4, and FBLN5, in prostate cancer, while two further ECM genes, SPOCK1 (testican) and TENC (tenascin C), appeared upregulated or unchanged.
|
17929269 |
2007 |
Malignant neoplasm of prostate
|
0.310 |
Biomarker
|
disease |
BEFREE |
Knockdown of MBP-1 in human prostate cancer cells delays cell cycle progression.
|
16762917 |
2006 |
Prostatic Neoplasms
|
0.310 |
Biomarker
|
group |
BEFREE |
Next, we investigated the therapeutic effectiveness of MBP-1 repressor domain on prostate tumors.
|
15705866 |
2005 |
Cutis Laxa, Autosomal Recessive, Type I
|
0.300 |
GermlineCausalMutation
|
disease |
ORPHANET |
Lethal cutis laxa with contractural arachnodactyly, overgrowth and soft tissue bleeding due to a novel homozygous fibulin-4 gene mutation.
|
19664000 |
2009 |
Cutis laxa, recessive, type I
|
0.300 |
GermlineCausalMutation
|
disease |
ORPHANET |
Lethal cutis laxa with contractural arachnodactyly, overgrowth and soft tissue bleeding due to a novel homozygous fibulin-4 gene mutation.
|
19664000 |
2009 |
Cutis Laxa, Autosomal Recessive, Type I
|
0.300 |
GermlineCausalMutation
|
disease |
ORPHANET |
Fibulin-4: a novel gene for an autosomal recessive cutis laxa syndrome.
|
16685658 |
2006 |
Cutis laxa, recessive, type I
|
0.300 |
GermlineCausalMutation
|
disease |
ORPHANET |
Fibulin-4: a novel gene for an autosomal recessive cutis laxa syndrome.
|
16685658 |
2006 |
Lung diseases
|
0.300 |
Biomarker
|
group |
GENOMICS_ENGLAND |
|
|
|
Ruptured thoracic aortic aneurysm
|
0.200 |
Biomarker
|
disease |
MGD |
|
|
|
Ruptured abdominal aortic aneurysm
|
0.200 |
Biomarker
|
disease |
MGD |
|
|
|
Aortic Aneurysm, Ruptured
|
0.200 |
Biomarker
|
disease |
MGD |
|
|
|
Thoracoabdominal aortic aneurysm, ruptured
|
0.200 |
Biomarker
|
disease |
MGD |
|
|
|
Arachnodactyly
|
0.120 |
GeneticVariation
|
disease |
BEFREE |
To date, several mutations in the fibulin-4 gene (FBLN4/EFEMP2) are known in patients whose major symptoms are vascular deformities, aneurysm, cutis laxa, joint laxity, or arachnodactyly.
|
27339457 |
2016 |
Arachnodactyly
|
0.120 |
GeneticVariation
|
disease |
BEFREE |
Lethal cutis laxa with contractural arachnodactyly, overgrowth and soft tissue bleeding due to a novel homozygous fibulin-4 gene mutation.
|
19664000 |
2009 |
Arachnodactyly
|
0.120 |
Biomarker
|
disease |
HPO |
|
|
|